New Robotic Surgical Systems in Urology: An Update

Theodore Cisu; Fabio Crocerossa; Umberto Carbonara; Francesco Porpiglia; Riccardo Autorino

Disclosures

Curr Opin Urol. 2021;31(1):37-42. 

In This Article

Versius

Based in Cambridge, UK, CMR Surgical started developing a portable and modular robotic surgical system, Versius, in 2014 (https://cmrsurgical.com/about/our-story/). With a footprint of just 38 cm × 38 cm, Versius is intended to be a versatile robotic platform that may be moved between operating rooms or hospitals. It includes an open surgical console with 3D-HD technology, three individually cart-mounted robotic arms with seven degrees of freedom and has the capability of allowing the surgeon to sit or stand. The Versius Trainer is a learning platform included with every surgical system (https://cmrsurgical.com/training/).

Soon after the Versius system was unveiled in 2018, a preclinical study demonstrated the usability of Versius in nine different operations in a human cadaveric model across general and colorectal surgery, gynecologic surgery, and urologic surgery including radical nephrectomy, radical prostatectomy, and pelvic lymph node dissection.[13,14] A year later, in 2019, Versius was introduced into the clinical setting for the first time in Pune, India. A single-site experience at this hospital in India was published of the first 30 radical hysterectomies in July 2020, demonstrating technical feasibility and clinical safety with two noted complications of ureterovaginal fistulae requiring ureteral stenting and laparoscopic ureteral reimplantation, respectively[15] (Table 2). In total, over 150 robotic surgeries on humans have been performed as of February 2020 including hysterectomies and cholecystectomies.

As of then, several hospitals in the UK have started to use Versius in clinic practice, with further expansion pending per NHS approval (https://cmrsurgical.com/transformative-surgical-robot-begins-first-nhs-procedures/). Additionally, Versius received TGA approval for use in Australia in February 2020 for clinical application in general surgery, gynecologic surgery, and urological surgery (https://cmrsurgical.com/versius-begins-operating-in-the-nhs-as-it-gets-the-green-light-in-australia/). CE marking has not yet been obtained for use across Europe.

processing....